Bank of America’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Sell |
46,553
-84,622
| -65% | -$943K | ﹤0.01% | 4786 |
|
|
2025
Q1 | $1.61M | Buy |
131,175
+106,727
| +437% | +$1.31M | ﹤0.01% | 4063 |
|
|
2024
Q4 | $274K | Buy |
24,448
+11,088
| +83% | +$124K | ﹤0.01% | 5090 |
|
|
2024
Q3 | $93.1K | Sell |
13,360
-3,958
| -23% | -$27.6K | ﹤0.01% | 5471 |
|
|
2024
Q2 | $131K | Buy |
17,318
+3,612
| +26% | +$27.3K | ﹤0.01% | 5296 |
|
|
2024
Q1 | $181K | Sell |
13,706
-18,199
| -57% | -$240K | ﹤0.01% | 5094 |
|
|
2023
Q4 | $329K | Buy |
31,905
+26,405
| +480% | +$272K | ﹤0.01% | 4887 |
|
|
2023
Q3 | $53.5K | Hold |
5,500
| – | – | ﹤0.01% | 5591 |
|
|
2023
Q2 | $24.7K | Sell |
5,500
-7,516
| -58% | -$33.7K | ﹤0.01% | 5788 |
|
|
2023
Q1 | $60.4K | Hold |
13,016
| – | – | ﹤0.01% | 5639 |
|
|
2022
Q4 | $19.4K | Buy |
13,016
+11,210
| +621% | +$16.7K | ﹤0.01% | 5945 |
|
|
2022
Q3 | $7K | Sell |
1,806
-1,370
| -43% | -$5.31K | ﹤0.01% | 6438 |
|
|
2022
Q2 | $16K | Sell |
3,176
-1,403
| -31% | -$7.07K | ﹤0.01% | 6431 |
|
|
2022
Q1 | $38K | Sell |
4,579
-2,299
| -33% | -$19.1K | ﹤0.01% | 6495 |
|
|
2021
Q4 | $69K | Buy |
6,878
+3,966
| +136% | +$39.8K | ﹤0.01% | 6219 |
|
|
2021
Q3 | $46K | Buy |
2,912
+875
| +43% | +$13.8K | ﹤0.01% | 6196 |
|
|
2021
Q2 | $48K | Buy |
+2,037
| New | +$48K | ﹤0.01% | 6041 |
|